open access

Vol 17, No 2 (2013)
Original paper
Published online: 2013-08-19
Get Citation

Ischemic heart disease and left ventricular hypertrophy, hypertension and lipid metabolism disturbances in hemodialysed patients

Maria Wanic-Kossowska, Elżbieta Pawliczak, Julia Popowska-Drojecka, Andrzej Tykarski
Nadciśnienie tętnicze 2013;17(2):175-183.

open access

Vol 17, No 2 (2013)
Prace oryginalne
Published online: 2013-08-19

Abstract

Background Coronary heart disease is present in 70% hemodialysed patients and it is the main cause of sudden death. The aim of the study was the assessement the changes incoronary arteries and answer if risk factors: left ventricular hypertrophy, hypertension and lipid disturbances have the relations with development of CVD.

Material and methods In 37 hemodialysed patients coronarography, echocardiography, 24-hour blood pressure monitoring,laboratory analysis and serum level of nitric oxide were assessed. The patients were devided for 3 subgroups: in 7 were no changes in coronary arteries, in 12 coronary arteries were occluded, in 17 occluded and calcified.

Results In all patients left ventricular hypertrophy was presentand its systolic-diastolic dysfunction. Hypertension waspresent in 30 patients. It was no differences in blood pressurein 3 subgroups.

Conclusions The relations between coronary artery changesand echocardiographic parameters and serum level of nitricacid, between echoradiographic parameters and serum levelof cholesterol, time of dialysis therapy, patients age, blood pressure could confirm that this risk factors for cardiovascular events play also a role for development ischemic heart disease.

Abstract

Background Coronary heart disease is present in 70% hemodialysed patients and it is the main cause of sudden death. The aim of the study was the assessement the changes incoronary arteries and answer if risk factors: left ventricular hypertrophy, hypertension and lipid disturbances have the relations with development of CVD.

Material and methods In 37 hemodialysed patients coronarography, echocardiography, 24-hour blood pressure monitoring,laboratory analysis and serum level of nitric oxide were assessed. The patients were devided for 3 subgroups: in 7 were no changes in coronary arteries, in 12 coronary arteries were occluded, in 17 occluded and calcified.

Results In all patients left ventricular hypertrophy was presentand its systolic-diastolic dysfunction. Hypertension waspresent in 30 patients. It was no differences in blood pressurein 3 subgroups.

Conclusions The relations between coronary artery changesand echocardiographic parameters and serum level of nitricacid, between echoradiographic parameters and serum levelof cholesterol, time of dialysis therapy, patients age, blood pressure could confirm that this risk factors for cardiovascular events play also a role for development ischemic heart disease.

Get Citation

Keywords

chronic kidney disease, hemodialysis, ischemicheart disease

About this article
Title

Ischemic heart disease and left ventricular hypertrophy, hypertension and lipid metabolism disturbances in hemodialysed patients

Journal

Arterial Hypertension

Issue

Vol 17, No 2 (2013)

Article type

Original paper

Pages

175-183

Published online

2013-08-19

Page views

725

Article views/downloads

1762

Bibliographic record

Nadciśnienie tętnicze 2013;17(2):175-183.

Keywords

chronic kidney disease
hemodialysis
ischemicheart disease

Authors

Maria Wanic-Kossowska
Elżbieta Pawliczak
Julia Popowska-Drojecka
Andrzej Tykarski

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl